Influenza Testing

One would think that with the fizzled 2009 pandemic H1N1 (pH1N1), flu wouldn’t be much of a story. In reality, the pandemic expedited FDA clearance of molecular testing options in addition to clarifying the performance parameters of the most common viral detection tests that labs or near-patient testing sites were using, such as rapid antigen tests, direct fluorescent antibody (DFA) and cell culture assays. Read more